More than 1.4 million people worldwide face the repercussions of acute coronary syndrome and one third of them have myocardial infarctions .

Human body is endowed with a self-regulating process called homeostasis, which maintains stability by adjusting conditions that are optimal for survival.
If homeostasis is successful, life continues; if unsuccessful, disaster or death ensues.

Optimal Remote ischemic preconditioning (ORIP) is a noninvasive therapeutic strategy that uses brief cycles of blood pressure cuff inflation and deflation to protect the myocardium against ischemia–reperfusion injury. REDOXER is a wearable device technology that triggers a cascade of cellular events in organ tissue (upper limbs) by subjecting it to alternate cycles of ischemic stress followed by reperfusion. Such treatment triggers homeostatic redox signaling, releasing protective molecules in circulation, which travel to all vital organs and protect them from subsequent ischemic or oxidative stress / injury.

Redoxer ensures that homeostasis succeeds and disaster is averted. Stress induced by reduced oxygen/blood supply (ischemia) to one organ triggers molecules (redox signalling) that protect all organs from damage or death. Redox signaling is cellular communication within a living system and is an essential enabler of homeostasis.